|
WASHINGTON, DC USA -- HIT/HIPAA UPDATE NEWS SERVICE™ -- FEBRUARY 26, 2021:  According to a recent patient survey, 53 percent of patients reported that they had not taken a prescription drug because it was too expensive. Of those patients, 94 percent reported they would have been willing to take a lower-cost alternative. Unfortunately, providers do not always have patient-specific benefit and cost information at the point of prescribing.
Join us on March 10th for a webinar that will highlight the importance of providers having complete eligibility, formulary, and benefit data in real time.
Experts will discuss how to deliver patient-specific benefit and cost information into an electronic workflow and how this empowers payers, prescribers, and pharmacists to address patient prescription cost concerns and make informed decisions that boost medication adherence and operational efficiencies.
Discussion topics will include:
Leveraging existing data so formulary information - along with preferred alternatives - reach physicians at the time of prescribing;
- How prescription benefit information ensures providers are aware of prescription insurance formulary status and less expensive alternatives;
- The benefits of downstream transactions like real-time benefit checks, electronic prior authorization and specialty enrollment; and
- An overview of the upgraded Formulary & Benefit Standard, set by The National Council for Prescription Drug Programs (NCPDP), to address drug identification inconsistencies and improve patient safety issues.
|
SPEAKERS:
|
Pooja Babbrah
Practice Lead for PBM Services
Point of Care Partners |
Dr. Andrew Mellin
VP, Chief Medical Information Officer
Surescripts |
Jen Covich Bordenick
Chief Executive Officer
eHealth Initiative
|
|
|
